Decatur, Ill.-based agribusiness giant Archer Daniels Midland (ADM) has posted earnings per share (EPS) of US$0.78 for the FY 2002, ended 30 June, compared to US$0.58 last year.


Meanwhile, operating profit increased to US$1bn for the full year, up from US$903m last year and including a gain from vitamin settlements of US$147m, and an US$83m charge for abandonment and write down of long lived assets.


G. Allen Andreas, chairman and CEO, commented: “We expect the challenging environment of the Q4 to continue as weather concerns dominate many of our markets. Our year end results showed continued progress in improving the return on our assets. We remain confident in the value of the global ADM franchise, and are building long-term value for our shareholders.”


Q4 results


Q4 net earnings were US$112m, compared with US$56m last year. This year’s results include a US$0.09 per share gain on the partial settlement of ADM’s claims related to vitamin antitrust litigation, a US$0.04 per share tax credit and an US$0.08 per share charge upon abandonment and write down of long lived assets.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Operating profit increased to US$223m from US$206m last year. The gain from vitamin settlements of US$93m less an US$83m charge upon abandonment and write down of long lived assets accounted for most of the increase.


Twelve month results


Net earnings for the full year were US$511m, up from US$383m last year and including a loss of US$0.05 per share from private equity fund investments, a gain of US$0.03 per share from security transactions, a gain of US$0.14 per share from the vitamin antitrust litigation, a charge of US$0.08 per share from abandonment and write down of long lived assets and a tax credit of US$0.04 per share.


Earnings for FY 2001 include a loss of US$0.03 per share from private equity fund investments, a loss of US$0.05 per share from security transactions and a gain of US$0.14 per share from ADM’s unconsolidated affiliate, CIP.